Acrivon Therapeutics (ACRV) Depreciation And Amortization

Annual D&A

$536.00 K
+$172.00 K+47.25%

December 31, 2023


Summary


Performance

ACRV Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

Quarterly D&A

$251.00 K
+$23.00 K+10.09%

September 30, 2024


Summary


Performance

ACRV Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

TTM D&A

$852.00 K
+$118.00 K+16.08%

September 30, 2024


Summary


Performance

ACRV TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

ACRV Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+47.3%+88.7%+66.4%
3 y3 years+4023.1%+88.7%+66.4%
5 y5 years+4023.1%+88.7%+66.4%

ACRV Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+1348.7%at high+457.8%at high+1793.3%
5 y5-yearat high+4023.1%at high+457.8%at high+1793.3%
alltimeall timeat high+4023.1%at high+457.8%at high+1793.3%

Acrivon Therapeutics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2024
-
$251.00 K(+10.1%)
$852.00 K(+16.1%)
Jun 2024
-
$228.00 K(+1.8%)
$734.00 K(+15.6%)
Mar 2024
-
$224.00 K(+50.3%)
$635.00 K(+18.5%)
Dec 2023
$536.00 K
$149.00 K(+12.0%)
$536.00 K(+4.7%)
Sep 2023
-
$133.00 K(+3.1%)
$512.00 K(+3.4%)
Jun 2023
-
$129.00 K(+3.2%)
$495.00 K(+11.5%)
DateAnnualQuarterlyTTM
Mar 2023
-
$125.00 K(0.0%)
$444.00 K(+22.0%)
Dec 2022
$364.00 K(+883.8%)
$125.00 K(+7.8%)
$364.00 K(+52.3%)
Sep 2022
-
$116.00 K(+48.7%)
$239.00 K(+94.3%)
Jun 2022
-
$78.00 K(+73.3%)
$123.00 K(+173.3%)
Mar 2022
-
$45.00 K
$45.00 K
Dec 2021
$37.00 K(+184.6%)
-
-
Dec 2020
$13.00 K
-
-

FAQ

  • What is Acrivon Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Acrivon Therapeutics?
  • What is Acrivon Therapeutics annual D&A year-on-year change?
  • What is Acrivon Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Acrivon Therapeutics?
  • What is Acrivon Therapeutics quarterly D&A year-on-year change?
  • What is Acrivon Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Acrivon Therapeutics?
  • What is Acrivon Therapeutics TTM D&A year-on-year change?

What is Acrivon Therapeutics annual depreciation & amortization?

The current annual D&A of ACRV is $536.00 K

What is the all time high annual D&A for Acrivon Therapeutics?

Acrivon Therapeutics all-time high annual depreciation & amortization is $536.00 K

What is Acrivon Therapeutics annual D&A year-on-year change?

Over the past year, ACRV annual depreciation & amortization has changed by +$172.00 K (+47.25%)

What is Acrivon Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of ACRV is $251.00 K

What is the all time high quarterly D&A for Acrivon Therapeutics?

Acrivon Therapeutics all-time high quarterly depreciation & amortization is $251.00 K

What is Acrivon Therapeutics quarterly D&A year-on-year change?

Over the past year, ACRV quarterly depreciation & amortization has changed by +$118.00 K (+88.72%)

What is Acrivon Therapeutics TTM depreciation & amortization?

The current TTM D&A of ACRV is $852.00 K

What is the all time high TTM D&A for Acrivon Therapeutics?

Acrivon Therapeutics all-time high TTM depreciation & amortization is $852.00 K

What is Acrivon Therapeutics TTM D&A year-on-year change?

Over the past year, ACRV TTM depreciation & amortization has changed by +$340.00 K (+66.41%)